Nov62023MHRA authorises enzyme inhibitor Anastrozole to prevent breast cancer in post-menopausal women HM Government TwitterLinkedinFacebookemailAnastrozole is now authorised as a preventative treatment for post-menopausal women at moderate or high risk of breast cancer. Follow this news feed: